Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
it has the potential to sensitize KRASdependent cancers to MEK inhibitor treatment
for 14 days) exerts antitumor activity on CRC in vivo
CID 11502183
Oncologist
Chemical Name: 2-bromo-N-[2-(2
Rebaudioside A desartan Cilexetil-d5 it has the potential toRebaudioside A is a steviol glycoside, glucosidase inhibitor with IC50 of 35. 01 g ml. can inhibit ATP sensitive K+ channels. Target: glucosidase IC 50: 35. 01 ug mLIn vitro: rebaudioside A stimulat the insulin secretion from MIN6 cells in a dose and glucose dependent manner. In conclusion, the insulinotropic effect of rebaudioside A is mediated via inhibition of ATP sensitive K+ channels and requires the presence of high glucose. In vivo: in vivo
US$ 400.00
US$ 400.00
US$ 125.00
US$ 600.00
US$ 1221.50
US$ 1250.00
US$ 19.99
US$ 120.00
US$ 750.00
US$ 175.00
US$ 150.00